Alterity Therapeutics Limited ATHE
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -4.89M | -4.78M | -3.16M | -3.15M | -1.59M |
| Total Depreciation and Amortization | 20.50K | 20.00K | 19.00K | 18.90K | 21.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 780.00K | 762.60K | 742.30K | 740.00K | 134.50K |
| Change in Net Operating Assets | -132.20K | -129.20K | -1.09M | -1.09M | 447.10K |
| Cash from Operations | -4.23M | -4.13M | -3.49M | -3.47M | -990.20K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 0.00 | 2.46M | 2.45M | -2.40M |
| Cash from Investing | 0.00 | 0.00 | 2.46M | 2.45M | -2.40M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -35.20K | -35.20K | -33.10K | -33.10K | -29.40K |
| Issuance of Common Stock | 0.00 | 0.00 | 10.19M | 10.19M | 21.09M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | -554.10K | -554.10K | -1.37M |
| Cash from Financing | -25.00K | -24.40K | 6.30M | 6.28M | 12.61M |
| Foreign Exchange rate Adjustments | 32.00K | 31.30K | -12.70K | -12.60K | -50.40K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.22M | -4.12M | 5.26M | 5.25M | 9.17M |